The Grace Therapeutics brand, founded in 2014 (United States), from 1 sister brand and 2214 competing brands. Grace Therapeutics is owned by Acasti Pharma Inc., listed on the stock exchange of New York The International Securities Identification Number (ISIN) of Acasti Pharma Inc. is CA00430K8730. Grace Therapeutics is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
Acasti Pharma Inc.
(Grace Therapeutics)
over 5 years*
USD 0.24